Investors Research Corp’s Hims & Hers Health HIMS Stock Holding History

Investors Research Corp’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14	Closed	-$291	–	840
2026 Q1	$291	Buy	+14	New	+$331	﹤0.01%	813

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Investors Research Corp's HIMS Position: Q2 2026 in Review

Investors Research Corp sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 14 shares — an estimated $291 sold.

Investors Research Corp first reported a position in HIMS in Q1 2026 and held it in 1 quarter. The position peaked at $291 in Q1 2026. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Investors Research Corp reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
Investors Research Corp sold 14 Hims & Hers Health shares in Q2 2026, an estimated $291.
Investors Research Corp first reported a position in Hims & Hers Health in Q1 2026 and held it in 1 quarter.
Investors Research Corp's Hims & Hers Health position peaked at $291 in Q1 2026.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.